Two Sigma Advisers
HRMY icon

Two Sigma Advisers’s Harmony Biosciences HRMY Stock Holding History

Two Sigma Advisers’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104,400
Closed -$3.91M – 980
2025
Q4 		$3.91M Buy
104,400
+64,581
+162% +$2.12M 0.01% 926
2025
Q3 		$1.1M Sell
39,819
-52,881
-57% -$1.82M ﹤0.01% 1413
2025
Q2 		$2.93M Sell
92,700
-48,100
-34% -$1.55M 0.01% 956
2025
Q1 		$4.67M Buy
140,800
+41,900
+42% +$1.5M 0.01% 815
2024
Q4 		$3.4M Buy
98,900
+17,700
+22% +$608K 0.01% 874
2024
Q3 		$3.25M Sell
81,200
-11,500
-12% -$404K 0.01% 859
2024
Q2 		$2.8M Sell
92,700
-59,500
-39% -$1.79M 0.01% 1014
2024
Q1 		$5.11M Sell
152,200
-500
-0.3% -$16K 0.01% 775
2023
Q4 		$4.93M Sell
152,700
-139,400
-48% -$3.89M 0.01% 807
2023
Q3 		$9.57M Sell
292,100
-110,700
-27% -$3.84M 0.02% 484
2023
Q2 		$14.2M Buy
402,800
+38,900
+11% +$1.34M 0.04% 388
2023
Q1 		$11.9M Sell
363,900
-56,600
-13% -$2.58M 0.03% 495
2022
Q4 		$23.2M Buy
420,500
+108,600
+35% +$5.97M 0.06% 299
2022
Q3 		$13.8M Buy
311,900
+74,900
+32% +$3.65M 0.04% 409
2022
Q2 		$11.6M Buy
237,000
+70,200
+42% +$3.16M 0.03% 467
2022
Q1 		$8.12M Buy
+166,800
New +$6.8M 0.02% 601

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Two Sigma Advisers's HRMY Position: Q1 2026 in Review

Two Sigma Advisers sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 104,400 shares — an estimated $3.91M sold.

Two Sigma Advisers first reported a position in HRMY in Q1 2022 and held it in 16 quarters. The position peaked at $23.2M in Q4 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Two Sigma Advisers reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 104,400 Harmony Biosciences shares in Q1 2026, an estimated $3.91M.
  • Two Sigma Advisers first reported a position in Harmony Biosciences in Q1 2022 and held it in 16 quarters.
  • Two Sigma Advisers's Harmony Biosciences position peaked at $23.2M in Q4 2022.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.